Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital. She is an infectious diseases physician and basic scientist. Her research focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection.

Charles has been working in the HIV/AIDS field since the mid-1980s as a clinical academic, describing the clinical spectrum of AIDS in Africa, then conducting formative trials of disease prophylaxis and antiretroviral therapy. He was appointed Head of the School of Public Health at The University of Queensland in 2013 and in 2014 became the first Queensland Professorial chair of HIV and STls. As a clinical researcher, he has published over 250 peer-reviewed papers.

Andrew is an internationally renowned authority in the transmission and prevention of HIV and sexually transmissible infections (STIs) and in the epidemiological relationship between immune deficiency, infection and cancer. He has worked in HIV research for more than thirty years, and at the Kirby Institute since 1995. His current research is mainly in two areas: first, the transmission and prevention of HIV and sexually transmitted infections in homosexual men, and second, the intersection between infection, altered immune function and cancer, particularly as it relates to HPV-related cancer and focusing on anal cancer.

Renata Ram is the Country Director for UNAIDS Pacific Office supporting 14 Pacific Island Countries. She is a dental therapist with over 15 years of public health experience in government, the private sector, academia, and international organizations. She is a holder of a Master of Health Policy from the University of Sydney.

A/Prof McMahon is an Infectious Diseases clinician researcher, Head of Infectious Diseases Clinical Research at the Alfred Hospital and also an ID physician at Monash Medical Centre. His research interests are in clinical trials focused on HIV Cure, HIV treatment and COVID-19. For ASHM he sits on the Board and chairs the Antiretroviral Guidelines Committee, he also sits on the Treatment & Chemoprophylaxis Panel for the National COVID-19 Clinical Evidence Taskforce

Mark was diagnosed HIV+ in 1985, and soon after left a promising career in industry to join both the Queensland AIDS Council and Queensland Positive People. Around 1990 he became involved in PLHIV advocacy and was soon elected to the President of NAPWHA. He then moved into Queensland Health and remained there for almost the next 20 years acting in Principle Policy Adviser roles in HIV and Sexual Health. Following retirement Mark joined the QPP Board as President.

Fiona is a GP in Brisbane who has worked as an S100 prescriber treating HIV since 2001. She is on the ASHM HIV Guidelines committee, the National Monkeypox Taskforce, and is current President of AusPATH (the Australian Professional Association for Trans Health).

Jules Kim is a Korean/Australian sex worker and the CEO of Scarlet Alliance, Australian Sex Workers Association -the peak national organisation that has been representing sex workers and sex worker organisations, collectives and projects throughout Australia since 1989. She is the Chair for the regional sex worker network, Asia Pacific Network of Sex Workers and was the UNAIDS Program Coordinating Board NGO Delegate for the Asia Pacific from 2019 to 2021. Jules represents sex workers on a number of government and UN committees and advisory mechanisms, has provided testimony and expert advice to parliamentary hearings and inquiries in relation to sex work, migration, trafficking and law reform. She has over 20 years’ experience in sex work, sex worker advocacy, community development and representation.

Alexis has worked in the health sector (both private and public) in Australia for the last 10 years, prior to that in South Africa also in the health and finance sectors for a further 10 years. He holds a degree in Chemical Engineering and an MBA with prior experience in finance and risk modelling.